Thieblemont, C., Jurczak, W., Kim, T. M., Linton, K., Cheah, C., Jiang, J., Atiya, M., Eskelund, C., Woods, D., Phillips, T. (2025). Epcoritamab (epcor) monotherapy offers long-term disease control in large B-cell lymphoma (LBCL): NHL-1 subgroup analysis in patients with prior chimeric antigen receptor T-cell (CAR T) therapy from the 3-year follow-up. Blood. https://doi.org/10.1182/blood-2025-1960